|
시장보고서
상품코드
2042573
피듀셜 마커 시장 : 제품별, 모달리티별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)Fiducial Markers Market, By Product, By Modality, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033 |
||||||
피듀셜 마커 시장 규모는 2025년에 1억 9,071만 달러로 평가되었으며, 2026년부터 2033년까지 CAGR 8.09%로 확대될 것으로 전망됩니다.
피듀셜 마커는 특정 부위(보통 종양이나 치료 부위)를 식별하기 위해 체내 또는 체표에 배치되는 소형 의료기기 또는 기준점이며, X-선, CT, MRI 등의 영상 진단에서 선명하게 나타나기 때문에 의사가 표적 부위를 정확하게 찾아내어 치료하는 데 도움을 줍니다. 정부와 공중보건기관이 치료의 안전성과 정확성에 더욱 주의를 기울이는 가운데, 암 치료 및 영상 진단 기술의 발전과 함께 피듀셜 마커 시장은 완만하게 성장하고 있습니다.
보다 넓은 관점에서 세계보건기구(WHO)는 암의 중요성을 지속적으로 강조하고 있으며, 각국에 정밀 기술 활용을 포함한 진단 및 치료 능력의 향상을 요구하고 있습니다. 한편, 유럽과 북미 등의 지역에서는 방사선 치료의 이용이 활발히 이루어지고 있으며, DICOM 등 미국 전기기기제조업체협회(NEMA)가 정의한 표준에 따라 표준화된 영상 진단 절차의 시행이 용이해지고 있습니다. 이러한 모든 요인들이 결합하여 정밀치료에서 피듀셜 마커의 활용 확대에 기여하고 있습니다.
피듀셜 마커 시장 - 시장 역학
정확한 의료 제공 지원, 정밀 암 치료에 대한 관심 증가
정밀하고 표적화된 암 치료에 대한 관심이 높아지면서 임상 현장에서 피듀셜 마커의 사용이 촉진되고 있습니다. 미국 국립암연구소(NCI)를 비롯한 여러 의료기관에서 지적한 바와 같이, 영상유도방사선치료는 보다 정확하게 방사선을 조사할 수 있고, 인접한 정상 조직에 대한 피폭을 줄일 수 있습니다. 이 치료법에서는 피듀셜 마커에 의해 보조되는 안정된 기준점을 활용합니다.
또한, 세계보건기구(WHO)는 전 세계적으로 암 환자 수가 지속적으로 증가하고 있으며, 이로 인해 의료 시스템은 치료의 질과 안전성을 향상시켜야 한다고 지적하고 있습니다. 업계 측면에서 볼 때, 보스턴 사이언티픽(Boston Scientific)은 방사선 치료 과정에서 임상의가 종양의 위치를 파악할 수 있도록 금으로 만든 피듀셜 마커를 개발했습니다. 이러한 발전 추세는 치료 계획에서 일관된 표적 설정과 환자 안전이 중심적인 고려사항이 되는 정밀의료 지향적 관행으로 단계적으로 전환되고 있음을 보여줍니다.
피듀셜 마커 시장 - 시장 세분화 분석:
세계 피듀셜 마커 시장은 제품, 양식, 용도, 최종사용자 및 지역에 따라 세분화되어 있습니다.
피듀셜 마커 시장은 제품별로 금속계 마커, 고분자계 마커, 생체흡수성 마커, 기타로 분류됩니다. 이 중 금속계 마커는 여러 시술에서 높은 영상 가시성과 임상적 신뢰성을 갖추고 있어 특히 큰 기여가 기대되고 있습니다. 이러한 마커, 특히 금이나 백금으로 만든 마커는 CT 스캔, X선, MRI 등의 영상 진단 장비를 통해 좋은 대비를 보여주기 때문에 널리 사용되어 왔습니다. 예를 들어, 보스턴 사이언티픽(Boston Scientific)은 여러 영상 진단 양식에서 가시성을 높이도록 설계된 백금 기반 물리적 마커를 제공하여 보다 정밀한 방사선 조사가 가능하도록 돕습니다. 임상적 관점에서 볼 때, 의학 저널에 발표된 연구에 따르면, 금색 마커는 이미지에서 높은 대비를 보여 정확한 종양 위치를 찾는 데 도움이 되지만, 특정 스캔에서 아티팩트가 발생할 수 있다고 합니다. 구조적 안정성과 조직 내 장기적인 위치 결정이 가능하기 때문에 정확성과 일관성이 중요한 고려사항인 많은 방사선 치료 워크플로우에서 선호되는 선택이 되고 있습니다.
모달리티별로 보면 피듀셜 마커 시장은 CT/CBCT, MRI, X선/투시, 하이브리드 MRI-LINAC 시스템, 초음파로 분류됩니다. CT/CBCT(컴퓨터 단층촬영/콘빔 CT)는 방사선 치료 워크플로우와의 높은 호환성과 일관된 이미지 선명도로 인해 중요한 부문으로 널리 인식되고 있습니다. 임상 연구에 따르면, 피듀셜 마커는 CT 및 CBCT 스캔에서 높은 가시성을 보여 영상 유도 방사선 치료에서 정확한 종양 위치 확인 및 일상적인 치료 정렬을 위해 일상적으로 사용되고 있습니다. 실용적인 관점에서 CT/CBCT 시스템은 일반적으로 방사선 치료 장비에 통합되어 임상의는 복잡한 추가 설정 없이도 치료 전과 치료 중에 종양의 위치를 확인할 수 있습니다. 이는 병원이나 암센터에서 장비를 자주 사용할 수 있는 쉬운 통합성을 통해 가능합니다. 업계 전문가에 따르면, CBCT는 안내 절차에서 직교 영상을 제공하는 동시에 방사선 피폭량을 줄일 수 있다고 합니다. 이러한 점들이 임상적으로 선호되고 있기 때문에 그 채택이 정당화됩니다. 이것이 CT/CBCT 기반 시술이 계속 채택되고 있는 이유 중 일부입니다.
피듀셜 마커 시장 - 지역별 인사이트
지역별로 보면 북미는 공중보건 프로그램 및 상환제도에 힘입어 꾸준한 도입이 이루어지고 있는 피듀셜 마커 시장에서 큰 점유율을 차지하고 있습니다. 예를 들어, 미국 국립보건원(NIH)과 같은 정부 기관은 암 연구와 방사선 치료의 발전을 위해 자금을 지원해왔습니다. 한편, 유럽의 의료제도는 연간 300만 명이 넘는 신규 암환자에 대응하기 위해 치료시설을 확충하고 있습니다. 이러한 혁신은 피듀셜 마커와 같은 정밀한 보조 장비의 도입으로 이어지고 있습니다.
북미뿐만 아니라 아시아태평양에서도 암 치료 체계의 확대와 환자 니즈 증가로 인해 괄목할 만한 성장이 예상됩니다. 세계보건기구(WHO)에 따르면, 암 환자의 절반 이상이 방사선 치료를 필요로 하지만, 특히 신흥 시장에서는 방사선 치료의 이용 기회가 제한되어 있습니다. 조사에 따르면, 이 지역에서는 약 948만 건의 암 사례가 보고되어 방사선 치료 장비에 대한 수요가 빠르게 증가하고 있습니다. 중국, 인도 등 각국 정부는 방사선 치료 시스템 도입을 지원하고 의료기술에 대한 접근을 용이하게 하는 한편, 기업들도 이러한 수요에 부응하기 위해 암 치료 솔루션을 점차 확대하고 있습니다. 이러한 노력은 정밀 유도 도구의 보급을 촉진하고, 진화하는 의료 환경에서 피듀셜 마커가 보다 일관성 있게 도입될 수 있도록 돕고 있습니다.
한국의 피듀셜 마커 시장 - 국가별 인사이트
한국의 피듀셜 마커 시장은 잘 정비된 암 의료 시스템과 첨단 치료기술에 대한 지속적인 공적 투자로 형성되고 있습니다. 보건복지부는 조기 진단과 정밀한 치료 계획을 중시하는 국가 암 대책 프로그램을 지원하고 있습니다. 국립암센터에 따르면, 암은 한국에서 가장 많이 언급되는 건강 문제 중 하나이며, 이에 따라 병원에서는 정밀하고 가이드된 치료의 도입을 추진하고 있습니다. 또한, 국내에는 방사선 치료 장비 및 영상 진단 장비가 다수 도입되어 치료 시행 시 피듀셜 마커 등의 가이드 장비를 사용할 수 있게 되었습니다. 정부가 지원하는 건강 보험 적용 범위의 확대는 첨단 종양학 서비스에 대한 접근을 더욱 촉진하고 임상의들이 정밀의료 기반 접근법을 보다 일관성 있게 도입할 수 있도록 돕고 있습니다.
목차
제1장 피듀셜 마커 시장 개요
제2장 주요 요약
제3장 피듀셜 마커 주요 시장 동향
제4장 피듀셜 마커 산업 분석
제5장 피듀셜 마커 시장 : 높아지는 지정학적 긴장의 영향
제6장 피듀셜 마커 시장 구도
제7장 피듀셜 마커 시장 : 제품별
제8장 피듀셜 마커 시장 : 모달리티별
제9장 피듀셜 마커 시장 : 용도별
제10장 피듀셜 마커 시장 : 최종사용자별
제11장 피듀셜 마커 시장 : 지역별
제12장 주요 벤더 분석 : 피듀셜 마커 산업
제13장 AnalystView의 전방위 전망
KSM 26.06.05Fiducial Markers Market size was valued at US$ 190.71 Million in 2025, expanding at a CAGR of 8.09% from 2026 to 2033.
Fiducial markers are small medical devices or reference points placed inside or on the body to identify a specific location, usually a tumour or treatment area, and appear clearly on imaging scans such as X-rays, CT, or MRI, helping doctors locate and treat target areas accurately. Fiducial markers market is slowly advancing with cancer treatment and imaging technologies, as governments and public health organizations pay greater attention to the safety and accuracy of delivering treatment.
From a broader perspective, the World Health Organization continues to highlight the growing importance of cancer, urging nations to improve their diagnostic and treatment capacities, including the use of precise techniques. On the other hand, there have been advancements in the use of radiation therapy in regions such as Europe and North America, while standards defined by the National Electrical Manufacturers Association, such as DICOM, make it easier to conduct standardized imaging procedures. All these factors contribute to the increasing use of fiducials in precision-based treatments.
Fiducial Markers Market- Market Dynamics
Rising focus on precision-based cancer treatment to support accurate care delivery
The growing emphasis on precise and targeted cancer treatment is encouraging the use of fiducial markers in clinical practice. As stated by the National Cancer Institute and other health care organizations, image-guided radiation therapy enables radiation to be delivered more precisely and with lower exposure to adjacent healthy tissue. This treatment method makes use of stable reference points, which are assisted by fiducial markers.
In addition, the World Health Organization highlights that cancer cases continue to rise globally, prompting healthcare systems to improve treatment quality and safety. From an industry side, Boston Scientific has developed gold fiducial markers that assist clinicians in identifying tumour positions during radiotherapy procedures. Such developments indicate a gradual shift toward precision-oriented care practices, where consistent targeting and patient safety are becoming central considerations in treatment planning.
Fiducial Markers Market- Segmentation Analysis:
The Global Fiducial Markers Market is segmented on the basis of Product, Modality, Application, End User, and Region.
The fiducial marker market is segmented by product into Metal-Based Markers, Polymer-Based Markers, Bio-Absorbable Markers, and others. Among these, metal-based markers are expected to contribute notably due to their strong imaging visibility and clinical reliability across multiple procedures. These markers, particularly those that are made of gold or platinum, have been widely used since they offer good contrast when seen through imaging devices like CT scans, x-rays, and MRIs. For instance, Boston Scientific offers platinum-based fiducial markers designed to enhance visibility across several imaging modalities, supporting more precise radiation delivery. From a clinical standpoint, studies published in medical journals indicate that gold markers demonstrate high contrast in imaging, which supports accurate tumour localisation, although they may create some artifacts in certain scans. Their structural stability and long-term presence within tissue further support dependable positioning, making them a preferred choice in many radiotherapy workflows where precision and consistency are important considerations.
By modality, the fiducial marker market is divided into CT/CBCT, MRI, X-ray/Fluoroscopy, Hybrid MRI-LINAC System, and Ultrasound. The CT/CBCT (Computed Tomography / Cone Beam CT) is widely considered an important segment due to its strong compatibility with radiotherapy workflows and consistent imaging clarity. Clinical studies indicate that fiducial markers are highly visible in CT and CBCT scans and are routinely used for accurate tumour localisation and daily treatment alignment in image-guided radiotherapy. From a practical standpoint, CT/CBCT systems are commonly integrated into radiotherapy equipment, allowing clinicians to verify tumour position before and during treatment without requiring additional complex setups. This is made possible by the ease of integration that ensures frequent use of the equipment in hospitals and cancer centers. According to industry experts, CBCT provides an orthogonal view as well as reduced radiation dose in guidance procedures. These aspects make it preferred clinically, hence justifying its adoption. These are among several reasons explaining why CT/CBCT-based procedures have continued to be adopted.
Fiducial Markers Market- Geographical Insights
From a geographical perspective, North America holds a significant share of the fiducial markers market and continues to see steady adoption supported by public health programs and reimbursement frameworks. For example, government organizations such as the National Institutes of Health have financed cancer studies and advancements in radiotherapy, whereas the health care systems of Europe have reacted to more than 3 million new cancer patients annually by enhancing their treatment facilities. These innovations lead to the adoption of precise aid devices such as fiducial markers.
In addition to North America, the Asia-Pacific region is expected to register meaningful growth due to expanding cancer care capacity and rising patient needs. According to the World Health Organization, more than half a percent of cancer patients need radiotherapy, but access is limited, particularly in emerging markets. Research has shown that the region had roughly 9.48 million cases of cancer reported, with demand for radiotherapy equipment growing rapidly. Governments in countries such as China and India are supporting installation of radiotherapy systems and easing access to medical technologies, while companies are gradually expanding oncology solutions to match this demand. These combined efforts are encouraging broader adoption of precision-guided tools, supporting more consistent integration of fiducial markers in evolving healthcare settings.
South Korea Fiducial Markers Market- Country Insights
South Korea's fiducial markers market is shaped by its well-structured cancer care system and continued public investment in advanced treatment technologies. The Ministry of Health and Welfare supports national cancer control programs that emphasize early diagnosis and precise treatment planning. As per the National Cancer Center Korea, cancer is among the most frequently mentioned health problems in Korea, hence prompting hospitals to embrace precise and guided therapies. Besides, South Korea boasts a vast amount of radiotherapy and imaging machines, which makes it possible to use guiding equipment such as fiducial markers while conducting the procedures. Government-backed health insurance coverage further facilitates access to advanced oncology services, allowing clinicians to integrate precision-based approaches more consistently.
Fiducial Markers Market- Competitive Landscape:
The competitive landscape of the fiducial markers market is characterized by the presence of established medical technology companies alongside specialized innovators, all focusing on enhancing clinical accuracy, imaging compatibility, and patient-specific treatment precision. Boston Scientific, Medtronic, CIVCO Radiotherapy, and Nanovi A/S contribute by virtue of their diverse range of products and strategic collaborations. Their key areas of concern include enhancing visibility, compatibility, and ease of placement, alongside distribution within hospitals and specialized clinics.
Companies are enhancing innovation, forming clinical partnerships, and adopting advanced imaging technologies to improve precision and treatment effectiveness. For example, in June 2025, Nanovi A/S advanced the BioXmark liquid biomarker in clinical practice, facilitating better adaptability in tumour detection. The companies are also increasing their focus on research activities and extending service networks to suit the requirements of precision medicine-based treatments. This strategy enables smooth acceptance, while also ensuring more effective healthcare provision.
Recent Developments:
In April 2026, QFIX expanded its radiotherapy positioning and guidance solutions, supporting integration with fiducial marker-based workflows to improve treatment setup accuracy in clinical environments. Enhancement supports more precise treatment alignment, helping clinicians improve targeting consistency while contributing to safer and more efficient radiotherapy procedures.
In March 2026, Eckert & Ziegler strengthened its oncology portfolio by enhancing radiotherapy-related product offerings, including components used in precision targeting solutions such as fiducial markers. This step reflects continued focus on precision oncology, supporting improved treatment accuracy while aligning product offerings with evolving radiotherapy practice requirements.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL FIDUCIAL MARKERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- CIVCO Radiotherapy
- IZI Medical Products
- Boston Scientific Corporation
- Medtronic plc
- Nanovi A/S
- Naslund Medical AB
- QlRad Inc.
- IBA Dosimetry GmbH
- Best Medical International
- Carbon Medical Technologies
- Beekley Medical
- Stellar Medical
- Varian Medical Systems
- AngioDynamics
- RaySearch Laboratories
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033
- Metal-Based Markers
- Polymer-Based Markers
- Bio-Absorbable Markers
- Liquid-Based Markers
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033
- CT/CBCT
- MRI
- X-ray/Fluoroscopy
- Hybrid MRI-LINAC System
- Ultrasound
GLOBAL FIDUCIAL MARKERS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Liver and Pancreatic Cancer
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Hospitals
- Cancer Specialty Centers
- Ambulatory Radiotherapy Clinics
- Others
GLOBAL FIDUCIAL MARKERS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Table of Contents
1. Fiducial Markers Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Fiducial Markers Market Snippet by Product
- 2.1.2. Fiducial Markers Market Snippet by Modality
- 2.1.3. Fiducial Markers Market Snippet by Application
- 2.1.4. Fiducial Markers Market Snippet by End User
- 2.1.5. Fiducial Markers Market Snippet by Country
- 2.1.6. Fiducial Markers Market Snippet by Region
- 2.2. Competitive Insights
3. Fiducial Markers Key Market Trends
- 3.1. Fiducial Markers Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Fiducial Markers Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Fiducial Markers Market Opportunities
- 3.4. Fiducial Markers Market Future Trends
4. Fiducial Markers Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Fiducial Markers Market: Impact of Escalating Geopolitical Tensions
- 5.1. Impact of COVID-19 Pandemic
- 5.2. Impact of Russia-Ukraine War
- 5.3. Impact of Middle East Conflicts
6. Fiducial Markers Market Landscape
- 6.1. Fiducial Markers Market Share Analysis, 2025
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Fiducial Markers Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
- 7.1.2. Metal-Based Markers
- 7.1.3. Polymer-Based Markers
- 7.1.4. Bio-Absorbable Markers
- 7.1.5. Liquid-Based Markers
- 7.1.6. Others
8. Fiducial Markers Market - By Modality
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
- 8.1.2. CT/CBCT
- 8.1.3. MRI
- 8.1.4. X-ray/Fluoroscopy
- 8.1.5. Hybrid MRI-LINAC System
- 8.1.6. Ultrasound
9. Fiducial Markers Market - By Application
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
- 9.1.2. Prostate Cancer
- 9.1.3. Lung Cancer
- 9.1.4. Breast Cancer
- 9.1.5. Liver and Pancreatic Cancer
- 9.1.6. Others
10. Fiducial Markers Market - By End User
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
- 10.1.2. Hospitals
- 10.1.3. Cancer Specialty Centers
- 10.1.4. Ambulatory Radiotherapy Clinics
11. Fiducial Markers Market- By Geography
- 11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
- 11.2. North America
- 11.2.1. Overview
- 11.2.2. Fiducial Markers Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.8. U.S.
- 11.2.8.1. Overview
- 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.8.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.2.8.4. U.S. Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.2.9. Canada
- 11.2.9.1. Overview
- 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.2.9.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.2.9.4. Canada Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3. Europe
- 11.3.1. Overview
- 11.3.2. Fiducial Markers Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.8. Germany
- 11.3.8.1. Overview
- 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.8.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.8.4. Germany Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.9. UK
- 11.3.9.1. Overview
- 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.9.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.9.4. UK Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.10. France
- 11.3.10.1. Overview
- 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.10.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.10.4. France Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.11. Italy
- 11.3.11.1. Overview
- 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.11.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.11.4. Italy Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.12. Spain
- 11.3.12.1. Overview
- 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.12.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.12.4. Spain Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.13. The Netherlands
- 11.3.13.1. Overview
- 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.13.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.13.4. The Netherlands Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.14. Sweden
- 11.3.14.1. Overview
- 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.14.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.14.4. Sweden Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.15. Russia
- 11.3.15.1. Overview
- 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.15.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.15.4. Russia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.16. Poland
- 11.3.16.1. Overview
- 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.16.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.16.4. Poland Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.17. Denmark
- 11.3.17.1. Overview
- 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.17.4. Denmark Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.17.5. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.3.18. Rest of Europe
- 11.3.18.1. Overview
- 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.3.18.4. Rest of the Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.3.18.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Fiducial Markers Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.8. China
- 11.4.8.1. Overview
- 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.8.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.8.4. China Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.9. India
- 11.4.9.1. Overview
- 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.9.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.9.4. India Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.10. Japan
- 11.4.10.1. Overview
- 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.10.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.10.4. Japan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.11. South Korea
- 11.4.11.1. Overview
- 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.11.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.11.4. South Korea Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.12. Australia
- 11.4.12.1. Overview
- 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.12.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.12.4. Australia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.13. Indonesia
- 11.4.13.1. Overview
- 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.13.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.13.4. Indonesia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.14. Thailand
- 11.4.14.1. Overview
- 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.14.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.14.4. Thailand Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.15. Philippines
- 11.4.15.1. Overview
- 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.15.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.15.4. Philippines Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.16. Taiwan
- 11.4.16.1. Overview
- 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.16.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.16.4. Taiwan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.16.5. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.17. Vietnam
- 11.4.17.1. Overview
- 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.17.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.17.4. Vietnam Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.17.5. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.4.18. Rest of APAC
- 11.4.18.1. Overview
- 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.4.18.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.4.18.4. Rest of APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.4.18.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. Fiducial Markers Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.8. Brazil
- 11.5.8.1. Overview
- 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.8.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.5.8.4. Brazil Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.9. Mexico
- 11.5.9.1. Overview
- 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.9.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.5.9.4. Mexico Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.10. Argentina
- 11.5.10.1. Overview
- 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.10.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.5.10.4. Argentina Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.11. Colombia
- 11.5.11.1. Overview
- 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.11.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.5.11.4. Colombia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.5.12. Rest of LATAM
- 11.5.12.1. Overview
- 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.5.12.4. Rest of LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. Fiducial Markers Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.8. Saudi Arabia
- 11.6.8.1. Overview
- 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.8.4. Saudi Arabia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.9. United Arab Emirates
- 11.6.9.1. Overview
- 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.9.4. United Arab Emirates Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.10. Israel
- 11.6.10.1. Overview
- 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.10.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.10.4. Israel Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.11. Turkey
- 11.6.11.1. Overview
- 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.11.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.11.4. Turkey Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.12. Algeria
- 11.6.12.1. Overview
- 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.12.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.12.4. Algeria Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.13. Egypt
- 11.6.13.1. Overview
- 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.13.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.13.4. Egypt Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.14. Iran
- 11.6.14.1. Overview
- 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.14.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.14.4. Iran Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.14.5. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.15. Qatar
- 11.6.15.1. Overview
- 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.15.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.15.4. Qatar Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.15.5. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
- 11.6.16. Rest of MEA
- 11.6.16.1. Overview
- 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
- 11.6.16.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
- 11.6.16.4. Rest of MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
- 11.6.16.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
- 11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Fiducial Markers Industry
- 12.1. Competitive Benchmarking
- 12.1.1. Competitive Dashboard
- 12.1.2. Competitive Positioning
- 12.2. Company Profiles
- 12.2.1. CIVCO Radiotherapy
- 12.2.2. IZI Medical Products
- 12.2.3. Boston Scientific Corporation
- 12.2.4. Medtronic plc
- 12.2.5. Nanovi A/S
- 12.2.6. Naslund Medical AB
- 12.2.7. QlRad Inc.
- 12.2.8. IBA Dosimetry GmbH
- 12.2.9. Best Medical International
- 12.2.10. Carbon Medical Technologies
- 12.2.11. Beekley Medical
- 12.2.12. Stellar Medical
- 12.2.13. Varian Medical Systems
- 12.2.14. AngioDynamics
- 12.2.15. RaySearch Laboratories
- 12.2.16. Others
13. 360 Degree AnalystView
14. Appendix
- 14.1. Research Methodology
- 14.2. References
- 14.3. Abbreviations
- 14.4. Disclaimer
- 14.5. Contact Us
